+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prostate Cancer Drugs Market Research Reports

Benign prostatic hyperplasia - Pipeline Insight, 2024 - Product Thumbnail Image

Benign prostatic hyperplasia - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 60 Pages
  • Global
From
Metastatic Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Prostate Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
Castrate-resistant Prostate Cancer (CRPC) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Castrate-resistant Prostate Cancer (CRPC) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Metastatic Castration-Sensitive Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Castration-Sensitive Prostate Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Prostate Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Metastatic Castration Resistant Prostate cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Castration Resistant Prostate cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 150 Pages
  • Global
From
Prostate Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Prostate Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • August 2024
  • 150 Pages
  • Global
From
Castration-Resistant Prostate Cancer (CRPC) Treatment Market 2024-2028 - Product Thumbnail Image

Castration-Resistant Prostate Cancer (CRPC) Treatment Market 2024-2028

  • Report
  • December 2023
  • 160 Pages
  • Global
From
Benign Prostatic Hyperplasia Treatment Devices Market - Product Thumbnail Image

Benign Prostatic Hyperplasia Treatment Devices Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Prostate Cancer Devices Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Thumbnail Image

Prostate Cancer Devices Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • July 2024
  • 154 Pages
  • Global
From
Benign Prostatic Hyperplasia (BPH) Treatment Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Thumbnail Image

Benign Prostatic Hyperplasia (BPH) Treatment Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • July 2024
  • 151 Pages
  • Global
From
Castration-resistant Prostate Cancer Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030 - Product Thumbnail Image

Castration-resistant Prostate Cancer Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report
  • December 2023
  • 180 Pages
  • Global
From
Mitoxantrone (CAS 65271-80-9) Global Market Research Report 2024 - Product Thumbnail Image

Mitoxantrone (CAS 65271-80-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]), Cancer Type (Breast, Lung, Colon, Prostate), and End User (Hospital, Imaging Center, Pharmaceutical) - Forecast to 2031 - Product Thumbnail Image

Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]), Cancer Type (Breast, Lung, Colon, Prostate), and End User (Hospital, Imaging Center, Pharmaceutical) - Forecast to 2031

  • Report
  • February 2024
  • 209 Pages
  • Europe
From
U.S. Prostate Cancer Nuclear Medicine Diagnostics Market Size, Share & Trends Analysis Report by Type (SPECT, PET), PET Product (F-18, SR-82/RB-82), and Segment Forecasts, 2023-2030 - Product Thumbnail Image

U.S. Prostate Cancer Nuclear Medicine Diagnostics Market Size, Share & Trends Analysis Report by Type (SPECT, PET), PET Product (F-18, SR-82/RB-82), and Segment Forecasts, 2023-2030

  • Report
  • December 2023
  • 80 Pages
  • United States
From
Metastatic Prostate Cancer Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Metastatic Prostate Cancer Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Africa Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Africa Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 100 Pages
  • Africa
From
United States Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United States Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • United States
From
Prostate Cancer in the United States: Understanding the Prostate Cancer Patient Experience - Product Thumbnail Image

Prostate Cancer in the United States: Understanding the Prostate Cancer Patient Experience

  • Report
  • January 2024
  • 129 Pages
  • United States
Loading Indicator

The Prostate Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it can vary depending on the stage and severity of the disease. Common treatments include hormone therapy, chemotherapy, and radiation therapy. The Prostate Cancer Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Astellas Pharma, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly researching and developing new drugs to treat prostate cancer, as well as improving existing treatments. Show Less Read more